Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.

    SUBMIT

Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence

Disclaimer:

Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
News18 » India
1-min read

Delhi Court Grants Time Till May 4 to CBI, ED to Complete Probe in Aircel-Maxis Case

The trial court took up the matter on its own on January 28 and sought the status report from the CBI and the ED. They, however, sought more time and the court granted them two weeks.

PTI

Updated:February 20, 2020, 2:08 PM IST
facebookTwitter Pocket whatsapp
Delhi Court Grants Time Till May 4 to CBI, ED to Complete Probe in Aircel-Maxis Case
Image for representation.

New Delhi: A Delhi court on Thursday granted time till May 4 to the CBI and ED to complete the probe in the Aircel-Maxis matter against former Union Minister P Chidambaram and his son Karti.

The Enforcement Directorate told Special Judge Ajay Kumar Kuhar that Letters Rogatory (LRs) have been sent to four countries and their response were awaited in connection with the case.

LR is issued by courts on the request of an investigation agency when it wants information from another country.

The ED had on February 14 filed status reports of investigation in the cases and said active investigation into the matter was going on, while the CBI had stated that LR has been sent to Malaysia and the response is awaited.

The CBI status report had stated that LR had been sent to Malaysia and there were developments in the case.

The court had on January 28 "revived" the Aircel-Maxis cases filed by the Central Bureau of Investigation and the Enforcement Directorate against Chidambaram and his son that were earlier adjourned 'sine die'.

The case was adjourned 'sine die' -- without fixing any date for hearing -- on September 5 last year with the court noting that the two probe agencies were seeking "adjournment after adjournment".

The trial court took up the matter on its own on January 28 and sought the status report from the CBI and the ED. They, however, sought more time and the court granted them two weeks.

The court had also granted anticipatory bail to the father-son duo. It has been challenged in the Delhi High Court, which will hear the matter on March 4.

The probe agencies were investigating how Karti Chidambaram received clearance from the Foreign Investment Promotion Board (FIPB) for the Aircel-Maxis deal in 2006 when his father was the Union finance minister.

The CBI and the ED had alleged that P Chidambaram, as finance minister during the United Progressive Alliance rule, granted approval to the deal beyond his capacity benefitting certain persons, and received kickbacks.

Support the daily wage earners who have been hit the hardest by the COVID-19 crisis. Click here to contribute to the cause. #IndiaGives

The daily News18 Coronavirus COVID-19 newsletter - Get your copy here.

Subscribe to News18 Daybreak. Follow us on Twitter, Instagram, Facebook, Telegram, TikTok and on YouTube

Read full article

Live TV

Countdown To Elections Results
To Assembly Elections 2018 Results

India

  • Active Cases

    2,650

     
  • Total Confirmed

    2,902

     
  • Cured/Discharged

    183

     
  • Total DEATHS

    68

     
Data Source: Ministry of Health and Family Welfare, India
Updated: April 04 (09:00 AM)
Hospitals & Testing centres

World

  • Active Cases

    832,271

     
  • Total Confirmed

    1,121,991

     
  • Cured/Discharged

    230,317

     
  • Total DEATHS

    59,403

     
Data Source: Johns Hopkins University, U.S. (www.jhu.edu)
Hospitals & Testing centres